News

Amplatzer, St. Jude Medical, ASD closure

The U.S. Food and Drug Administration (FDA) issued a warning this week about safety issues encountered with the St. Jude Amplatzer Atrial Septal Occluder (ASO), a transcatheter device used to seal...

heart failure treatments clinical trial/study bioventrix revivent LIVE

Bioventrix announced the presentation of scientific data demonstrating the durability of its Revivent Myocardial Anchoring System in 24 patients one year post-procedure. The data, which Andrew...

cardiovascular ultrasound structural heart valve repair hollywood presbyterian

A mother and her 25-week-old fetus are doing well after a team of physicians performed a successful in utero...

Sapien, TAVR, hybrid OR

As a cutting-edge technique, many hospitals around the country are investigating the development of their own TAVR programs. Starting a TAVR program requires a collaborative commitment to care and...

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013...

CardioLogical Solutions announced that it has been issued two additional patents for its family of aortic embolic protection devices designed to prevent stroke and other ischemic complications....

JenaValve, TAVI system, heart valve repair, CE Mark, JenaValve CE Mark

JenaValve Technology, Inc. announced that it has raised $62.5 million in a Series C venture round.

aortic valve, Edwards Lifesciences, SAPIEN, SAPIEN aortic valve

Edwards announced a new post-hoc data analysis from The PARTNER Trial demonstrated that diabetic patients with aortic stenosis in need of heart valve replacement, but at high surgical risk,...

Lotus Valve System, heart valves, Boston Scientific Corporation

Boston Scientific reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety and performance of the Lotus Valve System in...

JenaValve, TAVI system, heart valve repair, CE Mark, JenaValve CE Mark

JenaValve Technology Inc. has received CE (Conformite Europeenne) mark approval from European regulators for its transapical TAVI system for the treatment of aortic insufficiency (AI), also known...

Edwards Lifesciences Medtronic Injunction Sapien XT Heart Valves Germany

The injunction against sales of Medtronic's transcatheter heart valves in Germany — issued in a July 12, 2013, court ruling — has gone into effect, according to Edwards Lifesciences Corp. The...

Vascular closure devices have a definite niche in areas where they were not originally intended but have found frequent off-label use because of their utility.

Direct Flow Medical Inc. announced the first patient enrollment in the U.S. SALUS clinical trial. The trial will study the Direct Flow Medical Transcatheter Aortic Heart Valve System,...

September 9, 2013 — Keystone Heart, a company in the development of cerebral protection devices for interventional cardiology and cardiac surgery procedures, announced its TriGuard cerebral...

Transcatheter aortic valve implantation (TAVI) is feasible in patients with bicuspid aortic valve (BV), according to research presented at European Society of Cardiology (ESC) Congress 2013 by Dr...

PFM Medical

August 30, 2013 — PFM Medical received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its Nit-Occlud Patent Ductus Arteriosus (PDA) device, a permanently implanted prosthesis...

Edwards Lifesciences Corp. announced that Japan's Central Social Insurance Medical Council (Chuikyo) has approved the recommendation by the Japanese Ministry of Health, Labor and Welfare's (MHLW)...

JenaValve TAVI System Canada

JenaValve Technology Inc. has successfully completed the first two implantations of its second-generation transapical JenaValve transcatheter aortic valve implantation (TAVI) system in Canada....

August 22, 2013 – BioVentrix announced the successful first use of its Revivent Myocardial Anchoring System via the Less Invasive Ventricular Enhancement (LIVE) procedure in Germany. The...

Colibri Heart Valve LLC announced that enrollment its first-in-human feasibility study is continuing, and early clinical results from the second implantation of the Colibri device confirm the...